Neurofibromatosis type 2
Active Research Protocols
- 08-N-0044 – A Prospective Natural History Study of Patients with Neurofibromatosis Type 2 (NF2)
- 10-N-0193 – Using Positron Emission Tomography (PET) to Predict Intracranial Tumor Growth in Neurofibromatosis Type II (NF2) Patients
- 11-C-0115 – Phase 2 Study of Bevacizumab in Children and Adults with Neurofibromatosis Type 2 and Symptomatic Vestibular Schwannoma
- 78-C-0039 – Clinical, Laboratory, and Epidemiologic Characterization of Individuals and Families at High Risk of Cancer
NOTE: PDF documents require the freeAdobe Reader.
This page was last updated: January 24, 2014